These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3705518)

  • 1. [Complex-formation of heparin with the plasma diabetogenic factor].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(6):80-2. PubMed ID: 2629244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the diabetogenic factor in hypercoagulation of the blood].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Fiziol Zh SSSR Im I M Sechenova; 1986 Mar; 72(3):373-6. PubMed ID: 3709867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural diabetogenic factor].
    Kudriashov BA
    Sov Med; 1989; (7):51-4. PubMed ID: 2678523
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetogenic factor in the blood plasma in diabetes mellitus].
    Kudriashov BA; Ponasenkova GV; Pytel' IuA
    Probl Endokrinol (Mosk); 1982; 28(5):61-4. PubMed ID: 7145885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recovery of the anticoagulation system function in patients with insulin-dependent diabetes by neutralization of the activity of diabetogenic factor].
    Kudriashov BA; Balabolkin MI; Ul'ianov AM; Liapina LA; Levitskaia ZI
    Vopr Med Khim; 1990; 36(3):79-81. PubMed ID: 2382439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the diabetogenic factor in the activation of the blood coagulation system in experimental alloxan diabetes].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Patol Fiziol Eksp Ter; 1986; (4):44-7. PubMed ID: 3797076
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isolation and various physico-chemical properties of diabetogenic factor from the blood of patients with diabetes].
    Kudriashov BA; Liapina LA; Azieva LD
    Vopr Med Khim; 1989; 35(6):63-6. PubMed ID: 2629241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dependence of the blood plasma activity of the diabetogenic factor in animals on the functional depression of the anticoagulating system induced by an atherogenic diet].
    Kudriashov BA; Ul'ianov AM; Bazaz'ian GG
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1986; (2):50-3. PubMed ID: 3697425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physicochemical properties of the diabetogenic factor and its complex with heparin].
    Kudriashov BA; Ammosova IaM; Liapina LA; Ul'ianov AM
    Farmakol Toksikol; 1987; 50(3):49-52. PubMed ID: 3609278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental stimulation by protamine sulfate of the hyperglycemic action of the diabetogenic factor].
    Kudriashov BA; Pytel' IuA; Ul'ianov AM; Tarasov IuA
    Biull Eksp Biol Med; 1986 Jul; 102(7):16-8. PubMed ID: 3730582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stable reduction of endogenous insulin production in the body in experimental insulin-dependent diabetes].
    Kudriashov BA; Ul'ianov AM
    Vopr Med Khim; 1991; 37(4):40-3. PubMed ID: 1750208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complex compounds of heparin with blood proteins and their natural inhibitors in splenectomy in animals].
    Liapina LA; Kondashevskaia MV; Azieva LD; Soboleva GI
    Patol Fiziol Eksp Ter; 1990; (4):20-2. PubMed ID: 2080078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction of heparin with defensin, a nonenzymatic cationic protein from neutrophils].
    Liapina LA; Kondashevskaia MV; Kokriakov VN; Shamova OV
    Vopr Med Khim; 1992; 38(1):39-42. PubMed ID: 1441292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of the protein isolated from a blood albumin fraction in normal states and in diabetes].
    Liapina LA; Kudriashov BA; Baratova LA
    Vopr Med Khim; 1987; 33(6):69-71. PubMed ID: 3445550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.